These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 6108750)
1. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Smith JM; Baldessarini RJ Arch Gen Psychiatry; 1980 Dec; 37(12):1368-73. PubMed ID: 6108750 [TBL] [Abstract][Full Text] [Related]
2. Is tardive dyskinesia a unique disorder? Marsden CD Psychopharmacology Suppl; 1985; 2():64-71. PubMed ID: 2860661 [TBL] [Abstract][Full Text] [Related]
3. The reversibility of "permanent" tardive dyskinesia. Klawans HL; Tanner CM; Barr A Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520 [TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia in schizophrenics under 60 years of age. Kolakowska T; Williams AO; Ardern M; Reveley MA Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics. Altamura AC; Cavallaro R; Regazzetti MG Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540 [TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia: prevalence, incidence, and risk factors. Kane JM; Woerner M; Lieberman J Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662 [TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence. Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483 [TBL] [Abstract][Full Text] [Related]
9. A summary of current knowledge of tardive dyskinesia. Baldessarini RJ Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654 [TBL] [Abstract][Full Text] [Related]
10. Not all that moves is tardive dyskinesia. Khot V; Wyatt RJ Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323 [TBL] [Abstract][Full Text] [Related]
11. The current status of tardive dyskinesia. Sachdev PS Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. McGrath JJ; Soares KV Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546 [TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia in outpatients on depot phenothiazine. Neehall J West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166 [TBL] [Abstract][Full Text] [Related]
14. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Go CL; Rosales RL; Caraos RJ; Fernandez HH Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155 [TBL] [Abstract][Full Text] [Related]
15. Changing epidemiology of tardive dyskinesia: an overview. Jeste DV; Wyatt RJ Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Soares-Weiser K; Rathbone J Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425 [TBL] [Abstract][Full Text] [Related]